Amgen
Sort by
5 items
Filter
Items per page
-
Amgen’s obesity drug puts stock on pace for best day since 2009 as analysts predict big gains to come
One analyst says Amgen’s stock is in the ”early innings of a large move,” fueled by an experimental obesity drug.MarketWatch - Business -
Amgen ‘very encouraged’ by data from weight-loss-drug trial, as stock jumps
Shares of Amgen Inc. rallied in the extended session Thursday after the drug maker posted adjusted earnings above expectations and executives said they are “very encouraged” by preliminary data from a trial of an injectable weight-loss drug.MarketWatch - Business -
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.CNBC - Business -
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments.CNBC - Business